================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): February 10, 2003
MEDICIS PHARMACEUTICAL CORPORATION
(Exact Name of Registrant as Specified in Charter)
Delaware 0-18443 52-1574808
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
8125 North Hayden Road 85258-2463
Scottsdale, Arizona (Zip Code)
(Address of Principal Executive
Offices)
Registrant's telephone number, including area code: (602) 808-8800
N/A
------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
================================================================================
Item 5. Other Events
A copy of a press release appears as Exhibit 99.1 to this Current
Report and is incorporated herein by reference.
Item 7. Financial Statements and Exhibits
(a) Financial Statements of Business Acquired.
Not Applicable.
(b) Pro Forma Financial Information.
Not Applicable.
(c) Exhibits.
99.1 Copy of press release, dated February 10, 2003, issued by Medicis
Pharmaceutical Corporation.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICIS PHARMACEUTICAL CORPORATION
(Registrant)
Date: February 10, 2003 /s/ Mark A. Prygocki, Sr.
-------------------------------------------
Name: Mark A. Prygocki, Sr.
Title: Executive Vice President, Chief
Financial Officer, Corporate
Secretary and Treasurer
3
EXHIBIT INDEX
EXHIBIT
NUMBER DESCRIPTION
-------- -----------------------------------------------------------------
99.1 Copy of press release, dated February 10, 2003, issued by Medicis
Pharmaceutical Corporation.